Article
A multidrug efflux phenotype mutant of Streptococcus pyogenes.
The Journal of antimicrobial chemotherapy - 1 Mar 2003
Jones H E, Brenwald N P, Owen K A, Gill M J
Abstract excerpt
We describe a mutant of Streptococcus pyogenes NCTC 8198 with a multidrug efflux phenotype. A mutant selected with ethidium bromide showed a four-fold rise in MIC of norfloxacin, a 16-fold rise in MIC of ethidium bromide and an eight-fold rise in MIC of acriflavine when compared with the parent strain. The MICs were unaffected by the efflux pump inhibitors reserpine, rescinnamine and verapamil. The mutant's...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
